However, fewer studies have investigated thepotential of targeting ET-1 in conditions such as atherosclerosis or HF,underscoring the need for further research to provide a more comprehensiveunderstanding of the role of ET-1 inhibitors. Here, EDN1 is linked to atherosclerosis.